CASI PHARMACEUTICALS INC - COM (CASI)

CUSIP: 14757U109

Q4 2017 13F Holders as of 31 Dec 2017

Type / Class
Equity / COM
Total 13F shares
3,623,662
Share change
+1,235,259
Total reported value
$11,777,000
Price per share
$3.25
Number of holders
30
Value change
+$4,073,224
Number of buys
20
Number of sells
8

Quarterly Holders Quick Answers

What is CUSIP 14757U109?
CUSIP 14757U109 identifies CASI - CASI PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CASI PHARMACEUTICALS INC - COM (CASI) as of Q4 2017

As of 31 Dec 2017, CASI PHARMACEUTICALS INC - COM (CASI) was held by 30 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,623,662 shares. The largest 10 holders included Vanguard Group Inc, Wellington Shields Capital Management, LLC, Wellington Shields & Co., LLC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, PERCEPTIVE ADVISORS LLC, NORTHERN TRUST CORP, and BARCLAYS PLC. This page lists 30 institutional shareholders reporting positions in this security for the Q4 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.